Web Analytics

3 Latest Announced Rounds

$2,265.93M Raised in 95 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Rapafusyn Pharmaceuticals

start up
United States - Baltimore, Maryland
  • 25/06/2024
  • Series A
  • $28,000,000

Rapafusyn Pharmaceuticals is an emerging pharmaceutical development company located in Baltimore Maryland. Rapafusyn has licensed technology related to a novel class of natural product-like macrocycles from Johns Hopkins University School of Medicine and seeks to develop novel pharmaceuticals to treat patients having diseases and fulfill unmet medical needs.


Related People

Sean X. HuFounder

Sean X. Hu United States - New York, New York

> A leader with a track record of successfully building teams and growing a business;

> A recognized world class thought leader in personalized medicine strategies for both drug and molecular diagnostic product development, commercialization and marketing, as well as corporate level personalized medicine strategies;

> A seasoned strategist for the life science industries (pharmaceutical, diagnostics, biotech and beyond), well experienced in product commercialization / global marketing, portfolio optimization, corporate organizational and growth strategies, licensing and corporate development;

> Unique combination of strategic consulting and hands-on, industry operational experience;

> Educated in both science and business, with a BS in Organic Chemistry, a PhD in Genomics, and an MBA double majored in Strategic and Entrepreneurial Management;